In 2015, the Monaco Scientific Centre began research into paediatric cancers. Its work has resulted in the launch of a first clinical trial in 2023.
Around the world, more than 175,000 children and young adults are diagnosed with cancer, and nearly 96,000 of them die from a form of paediatric cancer. Despite the progress that has been made, cancer remains the second most common cause of mortality among under 15s, after accidents. The Monaco Scientific Centre therefore decided to conduct research into these rare diseases – childhood cancers account for 1–2% of all cancers – which are completely different from adult cancers. In 2015, a partnership agreement was reached between the Centre and the Fondation Flavien, the leading charity for childhood cancers and rare diseases in the Principality of Monaco.